Navigation Links
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2012
Date:1/25/2012

com.

Forward-Looking Statements Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers; the company's future business, including orders, revenues, backlog, or earnings growth; future financial results; market acceptance of or transition to new products or technology such as the TrueBeam platform and radiographic flat panel detectors, image-guided radiation therapy, stereotactic radiosurgery, filmless X-rays, proton therapy, and security and inspection, and any statements using the terms  "could," "believe," "expects," "appear," "confident," "outlook," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include the effect of economic conditions, including the lack of strength of the recovery from the global recession and the effect on capital spending; the impact of the 2010 federal health care legislation and any further health care reforms (including changes to Medicare and Medicaid), and/or changes in third-party reimbursement levels; currency exchange rates and tax rates; demand for the company's products; the company's ability to develop, commercialize, and deploy new products; the company's ability to meet Food and Drug Administration (FDA) and other regulatory requirements for product clearances or to comply with FDA and other regulatory regulations or procedures; changes in the regulatory environment, including with respect to FDA requirements; challenges associated with the successful commercialization of the company's particle therapy business; the effect of adverse publicity; the company's reliance on sole or limited-source suppliers; the impact of reduced or limited demand by purchasers of certain X-ray produc
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
... VANCOUVER, British Columbia, June 21, 2011 Enox Biopharma, Inc. ... East Investment in Innovation Conference on Wednesday, June 22 at ... Hyatt Regency Hotel in Boston. The IN3 ... and networking meeting. The meeting is designed to provide exposure ...
... Robbins & Myers, Inc. (NYSE: RBN ... approved its regular quarterly cash dividend payment of $0.045 ... 2011 to shareholders of record as of July 8, ... leading supplier of engineered equipment and systems for critical ...
Cached Medicine Technology:Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference 2
(Date:5/20/2013)... News) -- A new Canadian study has uncovered an ... less likely than men to get trauma center care ... to health care services in general have been recognized ... disparities extend to the treatment of severe injuries in ... at Sunnybrook Health Sciences Centre and the University of ...
(Date:5/20/2013)... 2013 The International Distance Skateboard Association has ... for the best long distance skaters to attend and compete. ... a venue of raising money for our local Boys & ... IDSA is the authority on long distance races throughout the ... event is safe and organized for all who want to ...
(Date:5/20/2013)... 2013 CosmosID, a leading data mining solutions company for ... collaboration results on analysis of labeling claims for the ... , The Food and Drug Administration (FDA) and CosmosID ... probiotics, four of which have been reported at the ... tests was to compare the identity of species and ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... Online education provides the convenience, flexibility ... not offer. According to the American Heart Association, ... classroom learning to eLearning due to changing economic ... maximize training budgets, but it is also proven ... 25–60%. A higher retention of content is probable, ...
Breaking Medicine News(10 mins):Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2
... TORONTO, February 16, 2011 − One of the tough challenges ... how to parent the surviving children, and the task begins ... From the moment their child dies, parents are faced with ... loss of a child and the ongoing, daily demands from ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, ... Physicians has released new guidelines recommending that doctors not ... sugar levels in patients in medical or surgical intensive ... with diabetes and without the condition. The college recommends ...
... screening and treatment of genitourinary cancers were released today in ... February 17-19, 2011, at the Orlando World Center Marriott in ... in a media presscast (press briefing via live webcast): ... cancer death for men with low initial PSAs: A large ...
... with Alzheimer,s disease or other dementias, and their families, ... plan for the patient,s progressive loss of ability to ... physician at the San Francisco VA Medical Center and ... patient is diagnosed with Alzheimer,s disease or dementia, the ...
... Men with prostate cancer may be twice as likely to have ... 20 than those without prostate cancer, a new French study suggests. ... 40s do not appear to face a similar boost in prostate ... do not face a higher risk of developing the cancer at ...
... , TUESDAY, Feb. 15 (HealthDay News) -- A review of ... Americans pop at the first sign of a cold may, in ... conducted by a team in India and published in the ... people have to stay away from work or school. "This ...
Cached Medicine News:Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 3Health News:Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer 2Health News:Financial planning a key but neglected component of Alzheimer's care, say researchers 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Zinc May Help Ease Common Cold: Analysis 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: